ASPG and acute lymphoblastic leukemia: The administration of asparaginase to ALL patients depletes the serum asparagine due to its hydrolytic activity, which will lead to inhibition of neoplastic cells proliferation process and in return it will die off and arrest in G-1 phase [9].